Life Science News
Latest updates from the biotech and pharma world
Amgen dances with Disco in $618M cancer target pact
Cancer biotech Disco lines up Amgen as first pharma partner
Amgen buys protein-degrading startup Dark Blue for up to $840M
Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs
Amgen to acquire Dark Blue Therapeutics for up to $840M
FDA broadens label for Amgen's Uplizna as it enters rare disease competition
Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx
Weight loss biotech Prolynx gets $70M, snags Amgen's obesity commercial leader as CEO
Amgen describes new GTPase KRAS mutant inhibitors
Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire
#Therapeutic Innovations#Forecast Report#Featuring Lonza#Novo Nordisk#Market Therapeutic
Cytiva Subsidiary Seeks to Quash Subpoena Issued in Amgen’s US Denosumab Litigation Against Accord & Intas - Pearce IP
#Subsidiary Seeks#Quash Subpoena#Subpoena Issued#Denosumab Litigation#Cytiva Subsidiary